Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–14 of 14 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
NCT06275620
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- University of Florida Jacksonville, Florida, United States
- Bascom Palmer Eye Institute Miami, Florida, United States
- Boston Children's Hospital Boston, Massachusetts, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States
NCT03584165
- Conditions
- Choroid Diseases, Choroideremia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +6 more
- Locations
-
- UCLA - Jules Stein Eye Institute Los Angeles, California, United States
- Vitreo Retinal Associates PA - The Millennium Center Gainesville, Florida, United States
- University of Miami Miami, Florida, United States
- Johns Hopkins Hospital Baltimore, Maryland, United States
NCT04671433
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- Shiley Eye Institute Jacobs Retina Center La Jolla, California, United States
- Childrens Hospital Los Angeles, California, United States
- Stanford Health Care Palo Alto, California, United States
- VitreoRetinal Associates, PA Gainesville, Florida, United States
NCT04312672
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
- Univ of Michigan Medical Center Ann Arbor, Michigan, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
- Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
NCT03252847
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- Massachusetts Eye and Ear Institute Boston, Massachusetts, United States
- Kellogg Eye Center Ann Arbor, Michigan, United States
- UPMC Eye Center Pittsburgh, Pennsylvania, United States
- Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
NCT03116113
- Conditions
- Cone-Rod Dystrophy, X-Linked, Type 1, X-Linked Retinitis Pigmentosa
- Locations
-
- Research Site Gainesville, Florida, United States
- Research Site Miami, Florida, United States
- Research Site Portland, Oregon, United States
- Research Site Philadelphia, Pennsylvania, United States
NCT04926129
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
- Research Site Miami, Florida, United States
NCT03314207
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- Duke Eye Center, Duke University Medical Center Durham, North Carolina, United States
- Casey Eye Institute, Oregon Health and Sciences University Portland, Oregon, United States
- Retina Foundation of the Southwest Dallas, Texas, United States
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
NCT04794101
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- Shiley Eye Institute Jacobs Retina Center La Jolla, California, United States
- Childrens Hospital Los Angeles Los Angeles, California, United States
- Stanford Health Care Palo Alto, California, United States
- VitreoRetinal Associates, PA Gainesville, Florida, United States
A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)
NCT06646289
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States
- University of Michigan Kellogg Eye Center Ann Arbor, Michigan, United States
- Moorfields Eye Hospital London, United Kingdom
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
NCT04850118
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- Retina Macula Institute of Arizona Scottsdale, Arizona, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- University of Florida Health Jacksonville, Department of Ophthalmology Jacksonville, Florida, United States
- Bascom Palmer Eye Institute- University of Miami Miami, Florida, United States
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
NCT04517149
- Conditions
- X-Linked Retinitis Pigmentosa
- Locations
-
- University of Colorado Aurora, Colorado, United States
- Vitreo Retinal Associates Gainesville, Florida, United States
- University of Michigan Kellogg Eye Center Ann Arbor, Michigan, United States
- Columbia University Medical Center/Edward Harkness Eye Institute New York, United States
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
NCT06333249
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- University of Florida Jacksonville, Florida, United States
- Boston Children's Hosptial Boston, Massachusetts, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States
- Cleveland Clinic Cleveland, Ohio, United States
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
NCT03316560
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, +2 more
- Locations
-
- Duke University Durham, North Carolina, United States
- Cincinnati Eye Institute Cincinnati, Ohio, United States
- Casey Eye Institute Portland, Oregon, United States
- Retina Foundation of the Southwest Dallas, Texas, United States